**NEW SPEAKERS ADDED**

Eddie Gibson, Oncology Business Unit Director, BMS

John De Wit, Business Unit Director, Oncology, Amgen

**NEW  TOPIC ADDED**

Budget Impact Models or Cost-effectiveness Analysis?

OVERVIEW

At last, the hottest topic in pharma gets the platform for discussion it needs and deserves with the inaugural Oncology Summit Europe. With Oncology expanding at nearly three times the rate of pharma as a whole, the opportunities for dynamic, unprecedented growth are vast.

eyeforpharma's Oncology Summit Europe conference will bring together a top selection of Pharma specialists and experienced professionals to share their knowledge, their views and give you insight into how they are dealing with the challenges and opportunities presented by the massive growth of oncology treatment.

Download brochure here

Come to the conference and you will gain insights into:

• Find Your Niche: Capitalise on the challenges and opportunities associated with targeted drugs
• HTAs and the Birth of EURONICE: Gain cross-regional insights into Health Technology Appraisals, ensure managed entry excellence and look forward to EURONICE
• Create Strong Stakeholder Collaboration: Work together to understand the patient experience and improve public perception - and your bottom line
• Pricing for Outcome: Time to Share Risk? Examine the role of payers and best-practice on effectively limiting risk to guarantee value
• Market Access Strategy: Get expert tips on how to effectively m anage oncology drug entry into a market where funding is limited
• Marketing Theory and Branding: Understand the rising importance of branding in oncology and assess what sets oncology marketing apart from classical mainstream pharma
• 2020 Vision: Forecast Trends and Future Models: Discover the recipe for future success in the most dynamic therapy area in pharma